Researchers have identified high expression of CTSB in human pancreatic ductal adenocarcinomas and pancreatic cancer stem cells, and demonstrated its association with poor survival and surgical outcomes (44, 45). The gene discussed is CTSB; the disease is familial pancreatic carcinoma.